Analyze Diet
Journal of the American Veterinary Medical Association2010; 236(10); 1085-1090; doi: 10.2460/javma.236.10.1085

Use of stored equine colostrum for the treatment of foals perceived to be at risk for failure of transfer of passive immunity.

Abstract: OBJECTIVE-To assess the use of stored equine colostrum for the treatment of foals perceived to be at risk for failure of transfer of passive immunity (FTPI). DESIGN-Cohort study. ANIMALS-232 Thoroughbred foals and 191 Thoroughbred mares (41 mares gave birth to 1 foal on 2 occasions). PROCEDURES-Postpartum, presuckle colostrum samples were collected from mares; samples with a colostral refractive index (cRI) > or = 23% were frozen (-20 degrees C [-4 degrees F]) and stored for > or = 7 days but < 2 years. Foals of dams that produced colostrum with a cRI value < 20% were treated with > or = 300 mL of stored colostrum that was thawed and administered via nasogastric tube on 1 to 4 occasions within 6 hours after parturition. Serum samples were obtained from colostrum-treated and nontreated foals 24 hours after treatment or suckling, respectively, for determination of serum IgG (sIgG) concentration. RESULTS-8 foals and their respective dams were excluded from the analyses. For the remaining 30 treated and 194 nontreated foals, mean +/- SD sIgG concentration was 1,597 +/- 574 mg/dL. Thirteen (5.8%) foals had sIgG concentrations < 800 mg/dL, of which 1 (0.4%) had an sIgG concentration < 400 mg/dL. Nine of these foals had suckled mares producing colostrum with a cRI value > or = 20%, and 2 foals had been treated with stored colostrum. CONCLUSIONS AND CLINICAL RELEVANCE-Treatment with stored colostrum appeared to be effective for prevention of FTPI in at-risk foals. However, foals were still at risk for FTPI despite suckling of or treatment with colostrum with adequate cRI values.
Publication Date: 2010-05-18 PubMed ID: 20470070DOI: 10.2460/javma.236.10.1085Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the effectiveness of stored horse colostrum in the treatment of foals believed to be at risk of failing to gain passive immunity after birth. The study utilized a cohort of Thoroughbred foals and mares, and the results suggest that treatment with stored colostrum appears beneficial, although some foals still faced the risk of insufficient passive immunity despite the colostrum treatment.

Objective and Design of the Study

  • The objective of the study was to evaluate the efficacy of using stored horse colostrum for treating foals considered at risk for failure of transfer of passive immunity (FTPI).
  • A cohort study design was used for the research. The study involved 232 Thoroughbred foals and 191 Thoroughbred mares, where 41 of the mares gave birth to one foal on two different occasions.

Procedures

  • Post childbirth, presuckle colostrum samples were collected from the mares. If the colostral refractive index (cRI) was 23% or above, the samples were frozen (-20 degrees C) and stored for at least a week but less than two years.
  • Foals, whose mothers produced colostrum with a cRI value of less than 20%, were treated with 300 mL or more of the stored colostrum. This was done within 6 hours following childbirth, administered via a nasogastric tube, and repeated one to four times.
  • Twenty-four hours after treatment or suckling, serum samples were obtained from both the treated and non-treated foals for the determination of serum IgG (sIgG) concentration.

Results

  • Eight foals and their related dams were excluded from the data analysis. For the remaining 30 treated and 194 non-treated foals, the average sIgG concentration was found to be 1,597 ± 574 mg/dL.
  • Thirteen foals (5.8% of the cohort) had sIgG concentrations less than 800 mg/dL. One foal (0.4% of the cohort) had an sIgG concentration less than 400 mg/dL.
  • Nine of these foals had suckled from mares producing colostrum with a cRI value of 20% or more, and two foals had been treated with stored colostrum.

Conclusion

  • According to the study, treatment with stored colostrum seemed to be effective in preventing FTPI in at-risk foals. However, the research noted that some foals were still at risk for FTPI even after suckling from or being treated with colostrum with adequate cRI values.

Cite This Article

APA
Nath LC, Anderson GA, Savage CJ, McKinnon AO. (2010). Use of stored equine colostrum for the treatment of foals perceived to be at risk for failure of transfer of passive immunity. J Am Vet Med Assoc, 236(10), 1085-1090. https://doi.org/10.2460/javma.236.10.1085

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 236
Issue: 10
Pages: 1085-1090

Researcher Affiliations

Nath, Laura C
  • Equine Centre, University of Melbourne, Werribee, VIC 3030, Australia. lc_fennell@yahoo.com.au
Anderson, Garry A
    Savage, Catherine J
      McKinnon, Angus O

        MeSH Terms

        • Animal Husbandry
        • Animals
        • Animals, Newborn
        • Animals, Suckling
        • Colostrum / immunology
        • Female
        • Horses / immunology
        • Immunity, Maternally-Acquired
        • Immunoglobulins / blood

        Citations

        This article has been cited 2 times.
        1. Barreto ÍMLG, Urbano SA, Oliveira CAA, Macêdo CS, Borba LHF, Chags BME, Rangel AHN. Chemical composition and lipid profile of mare colostrum and milk of the quarter horse breed. PLoS One 2020;15(9):e0238921.
          doi: 10.1371/journal.pone.0238921pubmed: 32925944google scholar: lookup
        2. Hedegaard CJ, Heegaard PM. Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems. Vet Immunol Immunopathol 2016 Jun;174:50-63.
          doi: 10.1016/j.vetimm.2016.04.007pubmed: 27185263google scholar: lookup